Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy

Details for Australian Patent Application No. 2006244446 (hide)

Owner Keryx Biopharmaceuticals, Inc.

Inventors Weiss, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006244446

PCT Pub. Number WO2006/121853

Priority 60/736,973 14.11.05 US; 60/679,096 05.05.05 US

Filing date 5 May 2006

Wipo publication date 16 November 2006

International Classifications

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 31/727 (2006.01)

A61K 31/728 (2006.01)

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/121853 Priority application(s): WO2006/121853

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244447-Token sharing system and method

2006244445-Anti-CD19 antibody therapy for autoimmune disease